Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07449039 · ClinicalTrials.gov registry record · NA

Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial

A NA study of Gestational Diabetes Mellitus in Pregnancy, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07449039 is a NA study of Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 50 participants, below the 1,870-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07449039, a NA study of Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.

Conditions Studied

Gestational Diabetes Mellitus in Pregnancy

Interventions

  • DEVICE Continuous Glucose Monistor

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-28
Est. Completion 2030-06
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07449039

The ClinicalTrials.gov registry entry for NCT07449039 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,870-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (97% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gestational Diabetes Mellitus in Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monistor is the first listed.

NCT07449039 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07449039 about?

NCT07449039 is a clinical study titled "Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial". This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and w...

What is the current status of trial NCT07449039?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-28. Estimated completion is 2030-06.

What conditions does trial NCT07449039 study?

This clinical trial studies the following conditions: Gestational Diabetes Mellitus in Pregnancy.

What interventions are being tested in trial NCT07449039?

The interventions under investigation include: Continuous Glucose Monistor (DEVICE).

Who is sponsoring clinical trial NCT07449039?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07449039 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gestational Diabetes Mellitus in Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gestational Diabetes Mellitus in Pregnancy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.